These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17327884)

  • 1. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.
    Capuron L; Pagnoni G; Demetrashvili MF; Lawson DH; Fornwalt FB; Woolwine B; Berns GS; Nemeroff CB; Miller AH
    Neuropsychopharmacology; 2007 Nov; 32(11):2384-92. PubMed ID: 17327884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.
    Haroon E; Felger JC; Woolwine BJ; Chen X; Parekh S; Spivey JR; Hu XP; Miller AH
    Brain Behav Immun; 2015 May; 46():17-22. PubMed ID: 25500218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.
    Haroon E; Woolwine BJ; Chen X; Pace TW; Parekh S; Spivey JR; Hu XP; Miller AH
    Neuropsychopharmacology; 2014 Jun; 39(7):1777-85. PubMed ID: 24481242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and psychopathology: lessons from interferon-alpha.
    Capuron L; Miller AH
    Biol Psychiatry; 2004 Dec; 56(11):819-24. PubMed ID: 15576057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome.
    Russell A; Hepgul N; Nikkheslat N; Borsini A; Zajkowska Z; Moll N; Forton D; Agarwal K; Chalder T; Mondelli V; Hotopf M; Cleare A; Murphy G; Foster G; Wong T; Schütze GA; Schwarz MJ; Harrison N; Zunszain PA; Pariante CM
    Psychoneuroendocrinology; 2019 Feb; 100():276-285. PubMed ID: 30567628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha-Induced Changes in NODDI Predispose to the Development of Fatigue.
    Dowell NG; Bouyagoub S; Tibble J; Voon V; Cercignani M; Harrison NA
    Neuroscience; 2019 Apr; 403():111-117. PubMed ID: 29292074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.
    Felger JC; Li L; Marvar PJ; Woolwine BJ; Harrison DG; Raison CL; Miller AH
    Brain Behav Immun; 2013 Jul; 31():153-60. PubMed ID: 23072726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression.
    Albrecht K; Droll H; Giesler JM; Nashan D; Meiss F; Reuter K
    Psychooncology; 2013 Sep; 22(9):1972-8. PubMed ID: 23288588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of interferon-beta to the monkey nervous system following intranasal administration.
    Thorne RG; Hanson LR; Ross TM; Tung D; Frey WH
    Neuroscience; 2008 Mar; 152(3):785-97. PubMed ID: 18304744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
    Kenis G; Prickaerts J; van Os J; Koek GH; Robaeys G; Steinbusch HW; Wichers M
    Int J Neuropsychopharmacol; 2011 Mar; 14(2):247-53. PubMed ID: 20667172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study.
    Pallanti S; Haznedar MM; Hollander E; Licalzi EM; Bernardi S; Newmark R; Buchsbaum MS
    Neuropsychobiology; 2010; 62(2):132-8. PubMed ID: 20588072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study.
    Bouilleret V; Semah F; Chassoux F; Mantzaridez M; Biraben A; Trebossen R; Ribeiro MJ
    Neurology; 2008 Jan; 70(3):177-84. PubMed ID: 18195263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes.
    Herting B; Beuthien-Baumann B; Pöttrich K; Donix M; Triemer A; Lampe JB; von Kummer R; Herholz K; Reichmann H; Holthoff VA
    Mov Disord; 2007 Mar; 22(4):490-7. PubMed ID: 17260333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial).
    Ziefle S; Egberts F; Heinze S; Volkenandt M; Schmid-Wendtner M; Tilgen W; Linse R; Boettjer J; Vogt T; Spieth K; Eigentler T; Brockmeyer NH; Heinz A; Hauschild A; Schaefer M
    J Immunother; 2011 May; 34(4):403-8. PubMed ID: 21499123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroanatomic correlates of psychopathologic components of major depressive disorder.
    Milak MS; Parsey RV; Keilp J; Oquendo MA; Malone KM; Mann JJ
    Arch Gen Psychiatry; 2005 Apr; 62(4):397-408. PubMed ID: 15809407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolism changes with 18F-fluorodeoxy- glucose-positron emission tomography in a patient with Cotard's syndrome.
    Ozkan N; Caliyurt O
    Aust N Z J Psychiatry; 2016 Jun; 50(6):600-1. PubMed ID: 26681266
    [No Abstract]   [Full Text] [Related]  

  • 18. Prefrontal cortical hypometabolism during low-dose interferon alpha treatment.
    Juengling FD; Ebert D; Gut O; Engelbrecht MA; Rasenack J; Nitzsche EU; Bauer J; Lieb K
    Psychopharmacology (Berl); 2000 Nov; 152(4):383-9. PubMed ID: 11140330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
    Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.